3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
25
Ovarian Neoplasms
19
Neoplasms
12
Fallopian Tube Neoplasms
12
Carcinoma, Hepatocellular
11
Endometrial Neoplasms
7
Neoplasm Metastasis
6
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Glioblastoma
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Lung Neoplasms
3
Liver Neoplasms
3
Digestive System Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Mouth Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Intestinal Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Brenner Tumor
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Astrocytoma
2
Interventions
Cyclophosphamide
6
fludarabine
4
Standard of Care
4
Practice Guidelines as Topic
3
Mycophenolic Acid
3
GSK2636771
3
venetoclax
2
trametinib
2
talquetamab
2
osimertinib
2
dabrafenib
2
X-Rays
2
Whole-Body Irradiation
2
Thiotepa
2
Tacrolimus
2
Specimen Handling
2
Mesna
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
thymoglobulin
1
sapanisertib
1
ruxolitinib
1
relatlimab
1
plerixafor
1
pertuzumab
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Bevacizumab
×
30 days
×
Clear all
No trials found.